583 related articles for article (PubMed ID: 16082221)
1. ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation.
Meulmeester E; Pereg Y; Shiloh Y; Jochemsen AG
Cell Cycle; 2005 Sep; 4(9):1166-70. PubMed ID: 16082221
[TBL] [Abstract][Full Text] [Related]
2. Dynamics in the p53-Mdm2 ubiquitination pathway.
Brooks CL; Gu W
Cell Cycle; 2004 Jul; 3(7):895-9. PubMed ID: 15254415
[TBL] [Abstract][Full Text] [Related]
3. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of p53 stabilization by ATM after DNA damage.
Cheng Q; Chen J
Cell Cycle; 2010 Feb; 9(3):472-8. PubMed ID: 20081365
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of HAUSP in vivo modulates p53 function.
Kon N; Kobayashi Y; Li M; Brooks CL; Ludwig T; Gu W
Oncogene; 2010 Mar; 29(9):1270-9. PubMed ID: 19946331
[TBL] [Abstract][Full Text] [Related]
6. ATM activates p53 by regulating MDM2 oligomerization and E3 processivity.
Cheng Q; Chen L; Li Z; Lane WS; Chen J
EMBO J; 2009 Dec; 28(24):3857-67. PubMed ID: 19816404
[TBL] [Abstract][Full Text] [Related]
7. Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2.
Meulmeester E; Maurice MM; Boutell C; Teunisse AF; Ovaa H; Abraham TE; Dirks RW; Jochemsen AG
Mol Cell; 2005 May; 18(5):565-76. PubMed ID: 15916963
[TBL] [Abstract][Full Text] [Related]
8. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.
Pereg Y; Shkedy D; de Graaf P; Meulmeester E; Edelson-Averbukh M; Salek M; Biton S; Teunisse AF; Lehmann WD; Jochemsen AG; Shiloh Y
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5056-61. PubMed ID: 15788536
[TBL] [Abstract][Full Text] [Related]
10. A dynamic role of HAUSP in the p53-Mdm2 pathway.
Li M; Brooks CL; Kon N; Gu W
Mol Cell; 2004 Mar; 13(6):879-86. PubMed ID: 15053880
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization.
Li M; Chen D; Shiloh A; Luo J; Nikolaev AY; Qin J; Gu W
Nature; 2002 Apr; 416(6881):648-53. PubMed ID: 11923872
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the p53/MDM2 interplay by HAUSP inhibitors.
Tavana O; Gu W
J Mol Cell Biol; 2017 Feb; 9(1):45-52. PubMed ID: 27927749
[TBL] [Abstract][Full Text] [Related]
13. MdmX inhibits ARF mediated Mdm2 sumoylation.
Ghosh M; Weghorst K; Berberich SJ
Cell Cycle; 2005 Apr; 4(4):604-8. PubMed ID: 15876864
[TBL] [Abstract][Full Text] [Related]
14. MDMX Recruits UbcH5c to Facilitate MDM2 E3 Ligase Activity and Subsequent p53 Degradation
Yang J; Jin A; Han J; Chen X; Zheng J; Zhang Y
Cancer Res; 2021 Feb; 81(4):898-909. PubMed ID: 33277368
[TBL] [Abstract][Full Text] [Related]
15. HAUSP as a therapeutic target for hematopoietic tumors (review).
Cheon KW; Baek KH
Int J Oncol; 2006 May; 28(5):1209-15. PubMed ID: 16596237
[TBL] [Abstract][Full Text] [Related]
16. Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.
Wang L; He G; Zhang P; Wang X; Jiang M; Yu L
Mol Biol Rep; 2011 Jan; 38(1):229-36. PubMed ID: 20333547
[TBL] [Abstract][Full Text] [Related]
17. Regulation of p53: a collaboration between Mdm2 and Mdmx.
Pei D; Zhang Y; Zheng J
Oncotarget; 2012 Mar; 3(3):228-35. PubMed ID: 22410433
[TBL] [Abstract][Full Text] [Related]
18. p53 regulation: teamwork between RING domains of Mdm2 and MdmX.
Wang X
Cell Cycle; 2011 Dec; 10(24):4225-9. PubMed ID: 22134240
[TBL] [Abstract][Full Text] [Related]
19. Mdmx promotes genomic instability independent of p53 and Mdm2.
Carrillo AM; Bouska A; Arrate MP; Eischen CM
Oncogene; 2015 Feb; 34(7):846-56. PubMed ID: 24608433
[TBL] [Abstract][Full Text] [Related]
20. Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation.
Xia M; Knezevic D; Tovar C; Huang B; Heimbrook DC; Vassilev LT
Cell Cycle; 2008 Jun; 7(11):1604-12. PubMed ID: 18520179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]